Alignment Healthcare, Inc. Common Stock (ALHC) is a publicly traded Healthcare sector company. As of May 21, 2026, ALHC trades at $16.58 with a market cap of $3.37B and a P/E ratio of 0.00. ALHC moved +1.80% today. Year to date, ALHC is -20.67%; over the trailing twelve months it is +6.25%. Its 52-week range spans $9.15 to $23.87. Analyst consensus is strong buy with an average price target of $24.50. Rallies surfaces ALHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ALHC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ALHC recently traded at $16.58. Market cap is $3.37B. P/E ratio is 0.00. Revenue is $3.95B.
| Metric | Value |
|---|---|
| Price | $16.58 |
| Market Cap | $3.37B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.87 |
| 52-Week Low | $9.15 |
| Volume | 562 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.95B |
| Net Income | $-978.00K |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.95B | $-978.00K | $0.00 |
| 2024 | $2.70B | $-128.07M | $-0.67 |
| 2023 | $1.82B | $-148.17M | $-0.79 |
| 2022 | $1.43B | $-149.64M | $-0.83 |
9 analysts cover ALHC: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.50.